ArticleOncotarget2016

miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer.

Mei Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.